Antidepressants: Mind-Altering Pills, Not Cures?

A British psychiatrist just told millions of antidepressant users their pills work less like medicine and more like a stiff drink.

Quick Take

Psychiatrist Joanna Moncrieff says antidepressants are “mind-altering” drugs similar in kind to alcohol and cannabis, not disease-correcting medicine.
She led a 2022 review finding no convincing evidence that depression comes from low serotonin, challenging decades of the “chemical imbalance” explanation.
Moncrieff argues antidepressants numb emotions broadly, rather than fixing a specific brain problem tied to depression.
Her claims remain contested inside psychiatry, where many doctors still defend the drugs’ effectiveness for their patients.

What Moncrieff Actually Said About Antidepressants

Asked directly if SSRIs are “a bit like alcohol,” Moncrieff answered without hesitation: “Absolutely.” She said antidepressants are “mind-altering, brain- and mind-altering drugs, like alcohol, like cannabis.” She was careful to add a caveat. The comparison isn’t about identical effects. It’s about the basic idea that these substances change how you feel, rather than repair some broken part of your brain.

Moncrieff has repeated this point elsewhere, stressing she isn’t claiming antidepressants and alcohol produce the same experience. “They are different sorts of drugs that have different sorts of effects,” she said in a separate interview. But she insists both work the same basic way. Both disrupt normal brain activity and change consciousness, rather than targeting a specific illness.

The Chemical Imbalance Theory Takes a Hit

Moncrieff’s argument didn’t come out of nowhere. In 2022, she and colleague Mark Horowitz published a massive review of existing research on serotonin and depression. Their conclusion was blunt. They found no convincing evidence that depression is caused by, or even linked to, lower serotonin levels or activity in the brain.

That finding struck at the foundation of how antidepressants have been marketed to the public for decades. Patients were told low serotonin caused their sadness, and pills would restore the balance. Moncrieff’s research team found most studies showed no such deficiency in depressed patients at all, undercutting the entire sales pitch behind millions of prescriptions.

A Drug-Centered View Versus the Disease Model

Moncrieff calls her approach the “drug-centered” model. Standard psychiatry uses a “disease-centered” model, assuming pills correct some specific chemical problem. Moncrieff argues instead that all psychoactive drugs, prescribed or recreational, alter mental states in everyone. That includes people with no diagnosis at all, similar to how alcohol loosens up a shy person at a party without fixing anything medically.

Under this view, antidepressants don’t cure sadness. They dull it, along with everything else a person feels. Moncrieff has described this as emotional “numbing,” reducing intense negative feelings like depression and anxiety, but also flattening joy and excitement. That trade-off, she argues, rarely gets explained to patients before they start taking the pills.

Why This Debate Matters Beyond Academic Circles

Roughly one in six adults in England takes antidepressants, and the numbers keep climbing on both sides of the Atlantic. If Moncrieff is right, doctors owe patients a far more honest conversation. Patients deserve to know they’re taking a mood-altering substance with real trade-offs, not a targeted fix for a diagnosed chemical problem. Informed consent depends on getting that distinction right, something Moncrieff has pushed for since at least 2017.

Pushback From the Psychiatric Mainstream

Not everyone in psychiatry agrees with Moncrieff’s conclusions, and this remains a live scientific dispute rather than settled fact. Critics point out that many patients and doctors report genuine symptom relief, even if the underlying mechanism isn’t fully understood. Moncrieff herself acknowledges the drugs are barely superior to placebo in clinical trials, a gap she says is rarely disclosed to patients weighing the decision to start treatment.

'Antidepressants are like alcohol or cannabis' | Joanna Moncrieff https://t.co/FQ4rbhlWWg via @YouTube

— Sebastian Meritless Tickbox Fasttrack-Blythe (@Jason_MI5) August 2, 2026